Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative randomized parallel-group PET study in newly diagnosed schizophrenia treated with aripiprazole or risperidone
2006-000980-26Phase 4Active
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia comparing Aripiprazole arm with Risperidone arm (2 arms). Primary endpoint: Brain glucose metabolic activity by PET. Started Mar 2007; status: active.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-000980-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000980-26.